Literature DB >> 32399674

Reduction of visceral fat could be related to the improvement of TBS in diabetes mellitus.

Hyun Uk Moon1, Nami Lee1, Yoon-Sok Chung1, Yong Jun Choi2.   

Abstract

INTRODUCTION: Diabetes has been proposed as a risk factor for increased skeletal fragility. Visceral fat is known to yield adverse effects on bone metabolism in people with diabetes. We investigated the relationship between the change in visceral fat mass over time and TBS or BMD.
MATERIALS AND METHODS: This retrospective study enrolled 690 (male: 367; female: 323) subjects with type 2 diabetes mellitus. Visceral fat mass, lumbar and femoral neck BMD, and lumbar spine TBS were measured via dual-energy X-ray absorptiometry (DXA), including the follow-up data within a 3-year period.
RESULTS: TBS significantly increased as visceral fat mass decreased in both sexes (p < 0.001), whereas lumbar BMD and femoral neck BMD showed meaningful changes only in men. The multiple regression model with adjustment for age, weight, creatinine level, lipid profile, HbA1C, and status of osteoporosis medication use revealed that TBS and femoral neck BMD were correlated with visceral fat mass. However, regarding longitudinal changes, only the change in visceral fat mass had a significant relationship with TBS (males: β = - 0.298, p < 0.001; females: β = - 0.216, p < 0.001).
CONCLUSIONS: The results of this study may suggest the beneficial effect of controlling visceral fat mass on bone health in type 2 diabetes patients. Besides, DXA-derived TBS could be a useful diagnostic tool for evaluating the bone changes according to metabolic changes in type 2 diabetes, which are not entirely achieved with BMD.

Entities:  

Keywords:  Bone mineral density; Diabetes mellitus; Trabecular bone score; Visceral fat mass

Mesh:

Year:  2020        PMID: 32399674     DOI: 10.1007/s00774-020-01107-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  6 in total

Review 1.  Evaluation of Quality and Bone Microstructure Alterations in Patients with Type 2 Diabetes: A Narrative Review.

Authors:  José Ignacio Martínez-Montoro; Beatriz García-Fontana; Cristina García-Fontana; Manuel Muñoz-Torres
Journal:  J Clin Med       Date:  2022-04-14       Impact factor: 4.964

2.  Body Composition as a Modulator of Bone Health Changes in Patients with Inflammatory Bowel Disease.

Authors:  Iulia Soare; Anca Sirbu; Miruna Popa; Sorina Martin; Cristian George Tieranu; Bogdan Mateescu; Mircea Diculescu; Carmen Barbu; Simona Fica
Journal:  Life (Basel)       Date:  2022-02-12

3.  Circulating SIRT1 and Sclerostin Correlates with Bone Status in Young Women with Different Degrees of Adiposity.

Authors:  Rossella Tozzi; Davide Masi; Fiammetta Cipriani; Savina Contini; Elena Gangitano; Maria Elena Spoltore; Ilaria Barchetta; Sabrina Basciani; Mikiko Watanabe; Enke Baldini; Salvatore Ulisse; Carla Lubrano; Lucio Gnessi; Stefania Mariani
Journal:  Nutrients       Date:  2022-02-25       Impact factor: 5.717

4.  Sodium-glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study.

Authors:  Kyoung Hwa Ha; Dae Jung Kim; Yong Jun Choi
Journal:  J Diabetes Investig       Date:  2022-03-04       Impact factor: 3.681

5.  Factors associated with trabecular bone score in postmenopausal women with type 2 diabetes and normal bone mineral density.

Authors:  Olga N Fazullina; Anton I Korbut; Vadim V Klimontov
Journal:  World J Diabetes       Date:  2022-07-15

6.  Effects of GLP-1 Receptor Agonists on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: A 52-Week Clinical Study.

Authors:  Ting-Ting Cai; Hui-Qin Li; Lan-Lan Jiang; Hui-Ying Wang; Meng-Hui Luo; Xiao-Fei Su; Jian-Hua Ma
Journal:  Biomed Res Int       Date:  2021-09-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.